Deliver Cardiac Results to Doctors in Half the Time

24 Feb 2011
Sarah Sarah
Marketing / Sales

Product news

Roche has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas 6000 analyser series, an integrated system designed for diagnostic labs with medium testing volumes. With a nine-minute duration, the assays are faster than any other cardiac immunoassay tests currently available on an integrated platform and enable labs to deliver results to doctors treating cardiac patients in about half the time of standard Roche tests.

The new nine-minute STAT immunoassay tests include troponin T, CK-MB, myoglobin and NT-proBNP and run on the cobas e 601 analyser, part of the cobas 6000 analyser series, an integrated platform that offers both clinical chemistry and immunoassay testing. The STAT tests are virtually equivalent to Roche's 18-minute tests in performance, precision and sensitivity.

Links

Tags

Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.
Deliver Cardiac Results to Doctors in Half the Time